PPP4R1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.767000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.506000E-01
Normal-vs-Stage2
3.325400E-01
Normal-vs-Stage3
6.132800E-01
Normal-vs-Stage4
2.513800E-01
Stage1-vs-Stage2
1.940240E-01
Stage1-vs-Stage3
4.945400E-01
Stage1-vs-Stage4
1.403010E-01
Stage2-vs-Stage3
8.907200E-01
Stage2-vs-Stage4
6.717800E-01
Stage3-vs-Stage4
7.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.838000E-01
Normal-vs-AfricanAmerican
6.061800E-01
Normal-vs-Asian
3.778800E-01
Caucasian-vs-AfricanAmerican
7.278600E-01
Caucasian-vs-Asian
8.113800E-01
AfricanAmerican-vs-Asian
6.819000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.092400E-01
Normal-vs-Female
3.288000E-01
Male-vs-Female
6.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.747800E-01
Normal-vs-Age(41-60Yrs)
1.651220E-01
Normal-vs-Age(61-80Yrs)
5.331800E-01
Normal-vs-Age(81-100Yrs)
6.630400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.792800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.970000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.627600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.990000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.341600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.455400E-01
Normal-vs-Daily Drinker
6.233800E-01
Normal-vs-Weekly Drinker
2.821000E-01
Normal-vs-Occasional Drinker
2.458000E-01
Normal-vs-Social Drinker
1.728570E-01
Non Drinker-vs-Daily Drinker
6.234000E-01
Non Drinker-vs-Weekly Drinker
2.196600E-01
Non Drinker-vs-Occasional Drinker
5.316200E-02
Non Drinker-vs-Social Drinker
7.335700E-02
Daily Drinker-vs-Weekly Drinker
6.563200E-01
Daily Drinker-vs-Occasional Drinker
2.073400E-01
Daily Drinker-vs-Social Drinker
4.047800E-01
Weekly Drinker-vs-Occasional Drinker
3.766600E-01
Weekly Drinker-vs-Social Drinker
6.347800E-01
Occasional Drinker-vs-Social Drinker
5.893000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.010000E-01
Normal-vs-Grade 2
8.636100E-02
Normal-vs-Grade 3
7.860300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.333800E-02
Grade 1-vs-Grade 3
6.479000E-03
Grade 1-vs-Grade 4
3.010000E-01
Grade 2-vs-Grade 3
1.059400E-01
Grade 2-vs-Grade 4
8.636100E-02
Grade 3-vs-Grade 4
7.860300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.507000E-01
Normal-vs-NonDiabetic
3.152200E-01
Diabetic-vs-NonDiabetic
1.206180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.443630E-01
Normal-vs-NoPancreatitis
4.267200E-01
Pancreatitis-vs-NoPancreatitis
1.957980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.340600E-01
Normal-vs-N1
3.477200E-01
N0-vs-N1
3.659200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.870100E-02
Normal-vs-TP53-NonMutant
7.065800E-01
TP53-Mutant-vs-TP53-NonMutant
4.01039999997632E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
